LINC01028

Across TCGA pan-cancer cohorts, LINC01028 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated LINC01028 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC01028 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01028 expression acts as an unfavorable survival marker, although some lineages such as MESO and ESCA show a favorable association.

MESO, KICH, and READ are the cancer types where LINC01028 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.515	0.284	<.001	77	view →
KICH	DFS	Tertile	III,IV	0.025	0.773	<.001	54	view →
READ	OS	Tertile	II,III,IV	0.287	0.829	.008	27	view →
ESCA	OS	Tertile	III,IV	0.645	0.352	.018	26	view →
LUAD	OS	Tertile	III,IV	0.779	0.316	.015	24	view →
LGG	DFS	Tertile	All	0.614	0.754	.006	21	view →
SKCM	DFS	Tertile	III,IV	0.429	0.219	.016	18	view →
PRAD	OS	Tertile	All	0.944	0.993	.001	12	view →
KIRC	DFS	Quartile	II,III,IV	0.293	0.545	.018	8	view →
BRCA	OS	Tertile	III,IV	0.904	0.792	.026	7	view →
KIRP	DFS	Tertile	III,IV	1.000	0.334	.021	6	view →
THCA	DFS	Tertile	II,III,IV	0.861	0.921	.021	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

LINC01028–MESO (OS)

Open the MESO breakdown →